Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-17 Purchase |
2021-09-20 9:19 pm |
DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner |
235,000 | $17 | $3,995,000 | 3,292,871 (Indirect) |
View |
| 2021-09-17 Purchase |
2021-09-20 4:30 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,400,000 | $17 | $23,800,000 | 786,407 (Indirect) |
View |
| 2021-09-15 Purchase |
2021-09-16 9:30 pm |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
6,000 | $17 | $102,000 | 89,998 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-14 Option Award |
2022-04-19 6:46 pm |
N/A 2032-04-14 |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
154,250 | $0 | 154,250 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 6:27 pm |
N/A 2032-03-31 |
DICE Therapeutics Inc. | DICE | Doyle Mittie Director |
42,500 | $0 | 42,500 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 6:22 pm |
N/A 2032-03-31 |
DICE Therapeutics Inc. | DICE | Bowers Lisa Director |
42,500 | $0 | 42,500 (Direct) |
View |
Ownership |
2022-04-01 6:12 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Doyle Mittie Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2022-04-01 6:06 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Bowers Lisa Director |
0 | $0 | 0 (Direct) |
View |
| 2021-12-30 Ownership |
2022-02-11 5:33 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
3,000 | $0 | 55,841 (Direct) |
View |
| 2021-09-17 Conversion |
2021-09-20 9:19 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner |
5,660,946 | $0 | 3,292,871 (Indirect) |
View |
| 2021-09-17 Conversion |
2021-09-20 4:30 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
7,617,822 | $0 | 786,407 (Indirect) |
View |
| 2021-09-14 Option Award |
2021-09-16 9:30 pm |
N/A 2031-09-14 |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
34,157 | $0 | 89,998 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 9:28 pm |
N/A 2031-09-14 |
DICE Therapeutics Inc. | DICE | TETLOW SHARON Director |
34,157 | $0 | 83,998 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 9:26 pm |
N/A 2031-09-14 |
DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director |
44,356 | $0 | 136,880 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 9:24 pm |
N/A 2031-09-14 |
DICE Therapeutics Inc. | DICE | Timothy Lu CMO |
100,064 | $0 | 262,349 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 9:23 pm |
N/A 2031-09-14 |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
95,856 | $0 | 280,862 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 9:21 pm |
N/A 2031-09-14 |
DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO |
129,011 | $0 | 345,761 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 9:18 pm |
N/A 2031-09-14 |
DICE Therapeutics Inc. | DICE | Judice Kevin CEO |
300,226 | $0 | 1,113,609 (Direct) |
View |
Ownership |
2021-09-14 9:25 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner |
0 | $0 | 3,057,871 (Indirect) |
View |
Ownership |
2021-09-14 7:37 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Zachary Stephen Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-09-14 7:34 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Scopa James Paul Director |
0 | $0 | 69,000 (Direct) |
View |
Ownership |
2021-09-14 7:32 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 3,808,911 (Indirect) |
View |
Ownership |
2021-09-14 7:30 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Gandhi Shaan-Chirag C Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-09-14 7:27 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | TETLOW SHARON Director |
0 | $0 | 69,000 (Direct) |
View |
Ownership |
2021-09-14 7:23 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director |
0 | $0 | 113,000 (Direct) |
View |
Ownership |
2021-09-14 7:20 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Timothy Lu CMO |
0 | $0 | 215,835 (Direct) |
View |
Ownership |
2021-09-14 7:15 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Simson Jake Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-09-14 7:10 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO |
0 | $0 | 231,625 (Direct) |
View |
Ownership |
2021-09-14 7:05 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO |
0 | $0 | 284,600 (Direct) |
View |
Ownership |
2021-09-14 7:01 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | Judice Kevin CEO |
0 | $0 | 971,644 (Direct) |
View |